La Biblioteca le brinda un dossier informativo actualizado sobre Coronavirus (COVID-19)

La Biblioteca le brinda un dossier informativo actualizado sobre Coronavirus (COVID-19)

Sociedades científicas: Recursos

Resumen de recomendaciones vigentes para la Campaña Nacional de Vacunación contra la COVID-19
https://bancos.salud.gob.ar/sites/default/files/2023-06/actualizacion-lt-covid.pdf

Dosis de refuerzo contra COVID-19 – Actualización
https://bancos.salud.gob.ar/sites/default/files/2023-05/memo-actualizacion-refuerzo-covid-19_03-5-2023.pdf

Manual del vacunador de Pfizer Bivariante
https://bancos.salud.gob.ar/sites/default/files/2023-01/2023-01-manual-pfizer-bivariante.pdf

OPS: ESAVI contra la COVID-19 y otras actualizaciones (abril 2023)
http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2023/05/Actualizacio%C3%ACn-perio%C3%ACdica-ESAVI-vacunas-COVID-19-ABRIL-2023.pdf

Monitor Público de Vacunación en tiempo real. Argentina
https://www.argentina.gob.ar/coronavirus/vacuna/aplicadas

Manual para Vacunadores Vacuna Sputnik Light
https://bancos.salud.gob.ar/sites/default/files/2023-02/manual-sputnik-light.pdf

Manual para Vacunadores Vacuna SPIKEVAX BIVARIANTE, Original/Omicron BA.4-5 (Vacuna COVID-19 ARNm, Moderna)
https://bancos.salud.gob.ar/sites/default/files/2023-02/manual-moderna-bivariante.pdf

Memorándum | Refuerzos Vacunación contra COVID-19 en niños, niñas y adolescentes
https://bancos.salud.gob.ar/sites/default/files/2023-01/refuerzos-vacunacion-contra-COVID-19-en-ni%C3%B1os-ni%C3%B1as-adolescentes.pdf

Memorándum | Uso de vacuna contra COVID-19 formulación pediátrica del laboratorio Moderna
https://bancos.salud.gob.ar/sites/default/files/2023-01/uso-de-vacuna-contra-COVID-19-formulacion-pediatrica-del-laboratorio-moderna.pdf

Manual del vacunador de Pfizer Bivariante
https://bancos.salud.gob.ar/sites/default/files/2023-01/2023-01-manual-pfizer-bivariante.pdf

Seguimiento de las variantes del SARS-CoV-2
https://www.who.int/es/activities/tracking-SARS-CoV-2-variants/tracking-SARS-CoV-2-variants

Análisis de la vacunación contra la COVID-19 en la Región de las Américas. Desglose por sexo y edad y en subpoblaciones seleccionadas
https://iris.paho.org/handle/10665.2/56734

Programa de optimización del uso de antimicrobianos durante la pandemia de COVID-19
https://www.medicinabuenosaires.com/revistas/vol82-22/n5/641.pdf

Salud recuerda la importancia de aplicar los refuerzos de vacuna contra COVID-19
https://www.argentina.gob.ar/noticias/salud-recuerda-la-importancia-de-aplicar-los-refuerzos-de-vacuna-contra-covid-19

Memo: Tercer refuerzo en personas de 18 años o más
https://bancos.salud.gob.ar/sites/default/files/2022-12/Tercer%20refuerzo%20en%20personas%20de%2018%20a%C3%B1os%20o%20m%C3%A1s.pdf

Frente a la suba de casos de COVID-19, Salud recomienda a la población aplicarse los refuerzos de vacunas
https://www.argentina.gob.ar/noticias/frente-la-suba-de-casos-de-covid-19-salud-recomienda-la-poblacion-aplicarse-los-refuerzos

19° Informe de seguridad en vacunas
https://bancos.salud.gob.ar/sites/default/files/2022-12/informe-19-noviembre-2022.pdf

Dudas generales sobre la vacunación contra la COVID-19. Información para el paciente
https://iris.paho.org/bitstream/handle/10665.2/56512/OPSFPLIMCOVID190032_spa.pdf?sequence=1&isAllowed=y

Prevención y Control de COVID-19 y otras Enfermedades Respiratorias Agudas en Residencias de Personas Mayores
https://portal-coronavirus.gba.gob.ar/docs/instituciones/Recomendaciones-para-residencias-de-personas-mayores.pdf

Vacunas de ARNm (Comirnaty y Spikevax) frente a la COVID-19 y riesgo de sangrado menstrual abundante
https://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2022/docs/NI_MUH_FV_07_2022-trastonos-menstruales.pdf

EVUSHELD®: tixagevimab/cilgavimab para el tratamiento de la COVID-19

http://www.navarra.es/NR/rdonlyres/6EAA15A8-75D9-4C43-B218-98D590FC247D/483026/FichaEvusheldTRATAMIENTO.pdf

II Informe sobre el impacto de la pandemia por SARS-CoV-2 en las coberturas nacionales de vacunación de Argentina
https://bancos.salud.gob.ar/sites/default/files/2022-11/II_informe_impacto_pandemia_sobre_coberturas_vacunacion.pdf

Lineamientos Técnicos | Tercer refuerzo
https://bancos.salud.gob.ar/sites/default/files/2022-11/lineamientos-tecnicos-tercer-refuerzo.pdf

Reacciones adversas a medicamentos utilizados para la COVID-19 en cinco países de América Latina
https://iris.paho.org/bitstream/handle/10665.2/56484/v46e1782022.pdf?sequence=1&isAllowed=y

Posible impacto de la COVID-19 en el aumento de casos en España de enfermedad neumocócica por cepas resistentes a antibióticos
https://www.univadis.es/viewarticle/posible-impacto-de-la-covid-19-en-el-aumento-de-casos-en-espana-de-enfermedad-neumococica-por-cepas-resistentes-a-antibioticos-771372

Comprueban que las mujeres vacunadas contra el COVID-19 transfieren protección a sus hijos a través de la leche materna, un hallazgo clave para los menores de 6 meses
https://www.agenciacyta.org.ar/2022/10/comprueban-que-las-mujeres-vacunadas-contra-el-covid-19-transfieren-proteccion-a-sus-hijos-a-traves-de-la-leche-materna-un-hallazgo-clave-para-los-menores-de-6-meses/

Andalucía: Preguntas frecuentes para Profesionales: Vacunación frente a al COVID-19
https://www.andavac.es/campanas/covid/informacion-para-profesionales/preguntas-frecuentes/

COVID-19. Informe n° 80 julio 2022 OPS
https://iris.paho.org/bitstream/handle/10665.2/56298/COVID-19SitRep80_spa.pdf?sequence=1&isAllowed=y

Eventos adversos de interés especial y eventos adversos supuestamente atribuibles a la vacunación o inmunización durante la introducción de las vacunas contra la COVID-19. Segunda edición
https://iris.paho.org/handle/10665.2/56207

Los pediatras de Atención Primaria recomiendan tomar precauciones frente a virus respiratorios en la primera vuelta al cole sin medidas anti-covid. Asociación Española de Pediatría (AEP)
https://www.aepap.org/sites/default/files/noticia/archivos-adjuntos/np_vuelta_al_cole_-_precauciones_virus.pdf

Optimización de la vacunación mediante la coadministración de vacunas contra la gripe y el Covid-19: orientación para farmacéuticos (FIP) (en inglés)
https://www.fip.org/file/5227

Criterios para valorar la administración de las nuevas alternativas terapéuticas antivirales frente a la infección por SARS-CoV-2
https://www.aemps.gob.es/medicamentos-de-uso-humano/acceso-a-medicamentos-en-situaciones-especiales/criterios-para-valorar-la-administracion-de-las-nuevas-alternativas-terapeuticas-

Programa de optimización del uso de antimicrobianos durante la pandemia de covid-19
https://www.medicinabuenosaires.com/revistas/vol82-22/destacado/original_7779.pdf

Seguridad y efectividad de vacuna COVID-19 SPUTNIK V en pacientes en diálisis
http://www.nefrologiaargentina.org.ar/numeros/2022/volumen20_1/PremioMiatello.pdf

ARGENVAC será una herramienta para convivir con el virus de COVID-19
http://solp-admin.diper-it.com/api/uploads/magazinearticles/ARGENVAC-sera-una-herramienta-para-convivir-con-el-virus-de-COVID-19/Preview_Revista_SOLP_62_Docena.pdf

Vacunación contra COVID-19 en niños y niñas de 6 meses a 3 años y refuerzo de 3 y 4 años de edad. Sociedad Argentina de Pediatría
https://www.sap.org.ar/uploads/documentos/documentos_vacunacion-contra-covid-19-en-ninos-y-ninas-de-6-meses-a-3-anos-y-refuerzo-de-3-y-4-anos-de-edad-306.pdf

Manual del Vacunador | Lineamientos Técnicos Vacunación con Moderna de 6 meses a 3 años y refuerzo de 3 y 4 años
https://bancos.salud.gob.ar/sites/default/files/2022-07/manual-vacunador-moderna-3-a-5-anos.pdf

Actualizaciones basadas en evidencia COVID-19
https://www.argentina.gob.ar/salud/conetec/actualizaciones

COVID y rellenos faciales ¿realmente debemos preocuparnos?
https://www.actasdermo.org/es-pdf-S0001731022004689

Preguntas frecuentes sobre la vacuna contra COVID-19
https://www.argentina.gob.ar/coronavirus/vacuna/preguntas-frecuentes

Glomerulonefritis por cambios mínimos post vacuna COVID-19 AstraZeneca
https://www.revistarenal.org.ar/index.php/rndt/article/view/758/1213

Declaración para los profesionales de la salud: cómo se regulan las vacunas contra la COVID-19 para garantizar que son seguras y eficaces
https://www.who.int/es/news/item/11-06-2021-statement-for-healthcare-professionals-how-covid-19-vaccines-are-regulated-for-safety-and-effectiveness

Lineamientos Técnicos | Primer refuerzo en niños y niñas de 5 a 11 años
https://bancos.salud.gob.ar/sites/default/files/2022-05/lineamientos-primer-refuerzo-personas-edad-5-11.pdf

Evidencia sobre las vacunas para COVID-19 en niñas, niños y adolescentes
https://www.evidencia.org/index.php/Evidencia/article/view/6997/4660

Manual del Vacunador | Vacuna MODERNA para uso pediátrico de 6 a 11 años
https://bancos.salud.gob.ar/sites/default/files/2022-04/manual-vacunador-moderna-desde-6-anos.pdf

Manual del Vacunador | Segundo Refuerzo COVID-19
https://bancos.salud.gob.ar/sites/default/files/2022-04/covid-19-lineamientos-tecnicos-segundo-refuerzo.pdf

El uso de corticoides inhalados para el tratamiento de COVID-19 podría disminuir el riesgo de hospitalización o muerte y el tiempo de resolución de síntomas
https://www.evidencia.org/index.php/Evidencia/article/view/7007/4676

Memorándum | Consideraciones para la habilitación de vacunación contra Covid-19 para viajeros
https://bancos.salud.gob.ar/sites/default/files/2022-03/memorandum_17-03_Vacunas_exterior.pdf

Baricitinib para el tratamiento de pacientes con COVID-19
https://www.argentina.gob.ar/sites/default/files/informe-rapido-covid-19-n15-baricitinib.pdf

COVID-19 plant-based vaccines
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/plant-based.html

La vacuna de ARN BNT162b2 frente a la COVID-19 parece segura y eficaz en niños mayores de 4 años
https://evidenciasenpediatria.es/files/41-14112-RUTA/5_ACV_Vacuna_COVID.pdf

Manual del vacunador. Vacuna Comirnaty de Pfizer-BioNTech pediátrica de 5 a 11 años
https://bancos.salud.gob.ar/sites/default/files/2022-03/manual-pfizer-pediatrica.pdf

Actualización de los Lineamientos Técnicos | Resumen de recomendaciones vigentes para la Campaña Nacional de Vacunación contra la COVID-19
https://bancos.salud.gob.ar/sites/default/files/2022-02/lineamientos-tecnicos_unificado-covid19-2022.pdf

Período de detección de SARS-CoV2 a través de PCR y Test de antígenos
https://gacetamedica.com/wp-content/uploads/2021/02/Periodo-de-detecci%C3%B3n-de-SARS-CoV-2-a-trav%C3%A9s-de-PCR-y-Test-de-ant%C3%ADgenos-2.pdf

Nuevas condiciones de aislamiento
https://bancos.salud.gob.ar/sites/default/files/2022-01/nuevas-condiciones-aislamiento-covid-19_2022-01-18.pdf

Recomendación de vacunación contra la COVID-19 en personas gestantes
https://bancos.salud.gob.ar/sites/default/files/2022-01/memo-personas-gestantes-11-01-22.pdf

Adecuación de las medidas para contactos estrechos de COVID-19
https://bancos.salud.gob.ar/sites/default/files/2022-01/comunicacion-medidas-ce.pdf

Algoritmos de manejo de casos, contactos estrechos y personas sintomáticas
https://bancos.salud.gob.ar/sites/default/files/2022-01/algoritmos-definiciones-covid19-2022.pdf

Memorándum | «Recomendación de intervalo de dosis de refuerzo en personal de salud y mayores de 60 años»
https://bancos.salud.gob.ar/sites/default/files/2021-12/memo-dosis-de-refuerzo-4-meses-PS-y-mayores-de-60.pdf

Memorándum: Recomendación de intervalo para la aplicación de la dosis de refuerzo de vacunas contra COVID-19
https://bancos.salud.gob.ar/sites/default/files/2021-12/memo%20Recomendacion%20de%20intervalo%20para%20aplicacion%20de%20la%20dosis%20de%20refuerzo%20Vacunas%20contra%20COVID-19.pdf

INVESTIGACIÓN REALIZADA POR PROFESIONALES DE LA UNIDAD DE TERAPIA INTENSIVA DE LA CLÍNICA COLÓN DE MAR DEL PLATA:
Pulmonary Edema in COVID-19 Treated with Furosemide and Negative Fluid Balance (NEGBAL): A Different and Promising Approach
https://www.mdpi.com/2077-0383/10/23/5599/htm

SEXTO CONGRESO COLOMBIANO DE ATENCIÓN FARMACÉUTICA: “IDENTIFICANDO Y PROYECTANDO EL PAPEL DE LA ATENCIÓN FARMACÉUTICA EN EL CONTEXTO DE LA POSPANDEMIA COVID-19
https://revistas.udea.edu.co/index.php/vitae/article/view/348083/20806693

RECOMENDACIONES HIGIÉNICO AMBIENTALES PARA LA FABRICACIÓN DE PRODUCTOS MÉDICOS EN EL CONTEXTO DE LA RECONVERSIÓN DE INDUSTRIAS GENERADA POR LA PANDEMIA COVID-19
https://safybi.org/wp-content/uploads/2021/01/GO-SAFYBI-003_Recomendaciones-higienico-ambientales-para-la-fabricacion-de-productos-medicos.v001.pdf

Informe especial de vigilancia de seguridad en vacunas en niños, niñas y adolescentes
https://bancos.salud.gob.ar/sites/default/files/2021-11/Informe_especial_de_vigilancia_de_seguridad_en_vacunas_en_ninios_ninas_adolescentes.pdf

Guía Clínica Para La Atención Al Paciente Long Covid/Covid Persistente
https://www.semg.es/images/2021/Documentos/GUIA_CLINICA_COVID_Persistent_20210501_version_final.pdf

Lineamientos técnicos: Dosis adicional al esquema primario y dosis de refuerzo (booster)
https://bancos.salud.gob.ar/sites/default/files/2021-11/lineamientos-tecnicos-COVID-19-booster.pdf

Vacunas contra la COVID-19. Boletín de errores de medicación de Cataluña
https://scientiasalut.gencat.cat/bitstream/handle/11351/6420/butll_prev_errors_medicacio_catalunya_2021_19_01_cas.pdf?sequence=2&isAllowed=y

RECOMENDACIONES PARA EL MANTENIMIENTO DE LAS BPF EN CONTEXTO DE COVID-19
https://safybi.org/wp-content/uploads/2021/01/GO-SAFYBI-004_Recomendaciones-para-el-mantenimiento-de-las.BPF_.v001.pdf|

Bloqueantes de receptores de angiotensina-II de novo para el tratamiento de pacientes con COVID-19
https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n10-bloqueantes-receptores.pdf

Lineamientos Técnicos: Resumen de recomendaciones vigentes para la Campaña Nacional de Vacunación contra la COVID-19 | 7 de octubre de 2021
https://bancos.salud.gob.ar/sites/default/files/2021-10/LT%20COVID-19%20unificado%20Octubre.pdf

Características de las vacunas contra la COVID-19 disponibles en Argentina
https://bancos.salud.gob.ar/sites/default/files/2021-10/caracteristicas-de-las-vacunas-contra-la-COVID19-disponibles-en-argentina.pdf

Vaxzevria (vacuna frente a la COVID-19 de AstraZeneca) y riesgo de síndrome de Guillain-Barré
https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/seguridad-1/2021-seguridad-1/vaxzevria-y-riesgo-de-sindrome-de-guillain-barre/

Seroneutralización de variantes SARS-CoV-2 Gamma (P.1, Manaos), Alpha (B.1.1.7, Reino Unido) y Lambda (C.37, Andina) en individuos vacunados con Sputnik V e individuos recuperados de la infección por SARS-CoV-2
http://pais.qb.fcen.uba.ar/files/reportes/informe_seroneutralizacion_C37_P1.pdf

EVALUACIÓN DEL POTENCIAL NEUTRALIZANTE DE LOS ANTICUERPOS NATURALES Y LOS GENERADOS POR LAS VACUNAS ASTRAZENECA, SINOPHARM Y SPUTNIK V FRENTE A LA VARIANTE DE PREOCUPACIÓN DELTA EN CÓRDOBA
https://www.cba.gov.ar/wp-content/uploads/2021/09/Informe-Delta-en-Co%CC%81rdoba-y-anticuerpos-neutralizantes-en-la-poblacio%CC%81n.pdf?csrt=6863230237421239545

Recomendaciones para el diagnóstico y tratamiento del Síndrome de Trombosis con Trombocitopenia tras la vacunación frente a COVID-19
http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/09/Bolet%C3%ADn-CIME-TTS-sept-2021-v.final_.pdf

Tromboprofilaxis farmacológica frente a no trombofilaxis para el tratamiento de pacientes hospitalizados con COVID-19
https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n8-tromboprofilaxis.pdf

Manual del Vacunador. Vacuna Comirnaty de Pfizer-BioNTech
https://bancos.salud.gob.ar/sites/default/files/2021-09/manual-vacunador-pfizer.pdf

COVID-19 Vaccine Media Hub
https://covidvaccinehub.org/

Ongoing Living Update of Potential COVID-19 Therapeutics Options: Summary of Evidence. Rapid Review
https://iris.paho.org/handle/10665.2/52719

Manual del Vacunador. Vacuna CONVIDECIA
https://bancos.salud.gob.ar/sites/default/files/2021-09/manual-vacunador-vacuna-convidecia-2021-septiembre.pdf

Azitromicina para el tratamiento de pacientes con COVID-19
https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n9-azitromicina.pdf

Tracking the vaccine race: A look at the vaccines in development to fight COVID-19.
https://graphics.reuters.com/HEALTH-CORONAVIRUS/VACCINE-TRACKER/xegpbqnlovq/

Ibuprofeno inhalado para el tratamiento de pacientes con COVID-19
https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n12-ibuprofeno-inhalado.pdf

RECOMENDACIÓN SOBRE ESQUEMAS HETERÓLOGOS DE VACUNACIÓN COVID-19
https://bancos.salud.gob.ar/sites/default/files/2021-08/recomendacion-sobre-esquemas-heterologos-de-vacunacion-contra-COVID19.pdf

Manual del Vacunador. Vacuna Moderna – 28 de julio de 2021
https://bancos.salud.gob.ar/sites/default/files/2021-07/Manual%20vacunador%20MODERNA.pdf

Spikevax1(vacuna de ARNm contra la COVID-19 [nucleósidos modificados])
https://www.ema.europa.eu/en/documents/overview/spikevax-previously-covid-19-vaccine-moderna-epar-medicine-overview_es.pdf

Recomendaciones para el Abordaje Terapéutico de Covid-19 en Niños, Niñas y Adolescentes
https://bancos.salud.gob.ar/sites/default/files/2021-07/abordaje-nnya-covid_0.pdf

Farmacovigilancia de vacunas para COVID-19
https://covid-19pharmacovigilance.paho.org/index.php

Clinical trials: COVID-19
https://www.recoverytrial.net/results

COVID-19 PREVENCIÓN DE TRANSMISIÓN POR AEROSOLES RECOMENDACIONES
https://www.argentina.gob.ar/sites/default/files/covid-19-prevencion-de-transmision-por-aerosoles-2021_0.pdf

Guía provisional de la ISTH para el diagnóstico y el tratamiento de la trombocitopenia trombótica inmune inducida por vacunas (TTIIV) (actualizada el 20 de Abril de 2021)
https://cdn.ymaws.com/www.isth.org/resource/resmgr/ISTH_VITT_Spanish_Guidance_F.pdf

Empleo de la vacuna Sputnik V en Argentina: Evaluación de respuesta humoral frente a la vacunación. Informe Final Enero‐Marzo 2021
https://www.conicet.gov.ar/wp-content/uploads/Informe-Sputnik_Buenos-Aires-13.04.2021..pdf

Ivermectina para el tratamiento de pacientes con COVID-19 y expuestos al SARS-CoV-2
https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n14-ivermectina.pdf

Esteroides sistémicos para el tratamiento de pacientes con COVID-19
https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n3-esteroides.pdf

Vacuna frente al COVID-19
https://seq.es/wp-content/uploads/2021/04/vacunas-covid-4.5.pdf

Ficha técnica de VITAMINA D (RACIM)
http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2020/12/RACIM-Vitamina-D-versi%C3%B3n-2-18.11.2020.pdf

Ficha técnica de VITAMINA C (RACIM)
http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2020/09/RACIM-Vit-C-versi%C3%B3n-1-01.07.2020-1.pdf

Suplementos vitamínicos (Vit. C, D) y Zinc en infección por COVID-19
https://www.iecs.org.ar/wp-content/uploads/IECS-IRR-788-Suplementos-vitami%CC%81nicos-y-Zinc-en-COVID-1.pdf

Ivermectina para COVID-19
https://www.iecs.org.ar/wp-content/uploads/IECS-IRR-823-VA.pdf

RACIM de ivermectina (actualización de la versión 3)
https://www.fundacionfemeba.org.ar/blog/farmacologia-7/post/racim-ivermectina-en-covid19-actualizacion-48807

Actualización del manual del vacunador de Sputnik V
https://bancos.salud.gob.ar/sites/default/files/2021-02/actualizacion-manual-vacunador-sputnik-v-10-02-21.pdf

Manual vacunador Sinopharm
https://bancos.salud.gob.ar/sites/default/files/2021-03/manual-vacunador-sinopharm_12-3-2021.pdf

Evaluación del riesgo por contagio de coronavirus SARS-CoV-2 y medidas preventivas recomendadas en la prestación de servicios profesionales farmacéuticos asistenciales (SPFA)
https://www.sefac.org/system/files/2020-06/Documento%20SEFAC%20evaluaci%C3%B3n%20de%20riesgos%20en%20SPFA%20y%20coronavirus_0.pdf

Ventilación y COVID-19 en la Industria
https://www.argentina.gob.ar/sites/default/files/ficha_tecnica_ventilacion_y_covid_150920.pdf

COVID-19: Acciones regulatorias de ANMAT
https://www.argentina.gob.ar/anmat/covid-19-acciones-regulatorias-de-anmat

PROTOCOLO DE ACTUACIÓN DESDE LAS FARMACIAS COMUNITARIAS
https://www.colfacor.org.ar/administrador_web/kcfinder/upload/files/info_coronavirus_farmacias%284%29.pdf

Impacto de los sistemas de ventilación en la transmisión del SARSCoV2Recomendaciones generales para los edificios de uso público
https://www.comunidad.madrid/sites/default/files/doc/sanidad/samb/doc_tec_ventilacion_el_sars-cov-2.pdf

Draft landscape of COVID-19 candidate vaccines
https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

COVID-19INTERACCIONES MEDICAMENTOSAS
https://www.argentina.gob.ar/sites/default/files/covid-19_interacciones-medicamentosas.pdf

 

Artículos científicos

Múltiples reacciones adversas graves a fármacos en un paciente luego de la infección por COVID-19. Informe de un caso
https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/260/134

Allergists and COVID-vaccine: which is the actual risk of reactions in allergic patients?
https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13006/11057

Association of Symptoms After COVID-19 Vaccination With Anti–SARS-CoV-2 Antibody Response in the Framingham Heart Study
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797552

Duration of immunity following full vaccination against SARS-CoV-2: a systematic review
https://archpublichealth.biomedcentral.com/counter/pdf/10.1186/s13690-022-00935-x.pdf

Comparative effectiveness of N95, surgical or medical, and non-medical facemasks in protection against respiratory virus infection: A systematic review and network meta-analysis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111143/pdf/RMV-32-0.pdf

Antiviral Activity of Echinacea Extract Appears to Include SARS-CoV-2
https://www.herbalgram.org/media/17794/032223.pdf

SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants
https://www.frontiersin.org/articles/10.3389/fimmu.2022.909995/pdf

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2209367?articleTools=true

Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2797625/strasser_2022_oi_221086_1666016864.51241.pdf

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
https://www.science.org/doi/epdf/10.1126/science.abo2523

A multinational Delphi consensus to end the COVID-19 public health threat
https://www.nature.com/articles/s41586-022-05398-2.pdf

Gout and Excess Risk of Severe SARS-CoV-2 Infection Among Vaccinated Individuals: A General Population Study
https://onlinelibrary.wiley.com/doi/10.1002/art.42339

Síndrome de Gianotti-Crosti de localización atípica en un adulto después de la vacunación contra el SARS-CoV-2
https://www.actasdermo.org/es-pdf-S0001731023000443

SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia
https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-022-02547-2.pdf

Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies
https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00663-6.pdf

Stevens-Johnson syndrome related with Comirnaty® coronavirus disease 2019 vaccine
https://www.scienceopen.com/document_file/3455a93b-637b-4964-8372-8a06712968c6/PubMedCentral/3455a93b-637b-4964-8372-8a06712968c6.pdf

Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants
https://www.nejm.org/doi/10.1056/NEJMc2209306

Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial
https://jamanetwork.com/journals/jama/fullarticle/2797483

UTILIZACIÓN PRECOZ DE TOCILIZUMAB EN PACIENTES INTERNADOS CON COVID-19 GRAVE Y CRÍTICA: UN ESTUDIO MULTICÉNTRICO EN LA PROVINCIA DE BUENOS AIRES
https://www.medicinabuenosaires.com/revistas/vol83-23/original_7941.pdf

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6
https://www.nejm.org/doi/pdf/10.1056/NEJMc2212117?articleTools=true

Shoulder injury related to vaccine administration (SIRVA): What do we know about its incidence and impact?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576975/pdf/main.pdf

Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial
https://www.bmj.com/content/bmj/379/bmj-2022-072175.full.pdf

Hypertension and Excess Risk for Severe COVID-19 Illness Despite Booster Vaccination
https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.122.19694

Mechanisms of COVID-19 pathogenesis in diabetes
https://journals.physiology.org/doi/epdf/10.1152/ajpheart.00204.2022

Efficacy of Combined Visual-Olfactory Training With Patient-Preferred Scents as Treatment for Patients With COVID-19 Resultant Olfactory Loss
A Randomized Clinical Trial
https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2799843

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB
https://www.nejm.org/doi/pdf/10.1056/NEJMc2214302?articleTools=true

Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639791/pdf/main.pdf

Primary hypertension, anti-hypertensive medications and the risk of severe COVID-19 in UK Biobank
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0276781&type=printable

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2118542?articleTools=true

Efficacy of olive leaves extract on the outcomes of hospitalized covid-19 patients: A randomized, triple-blinded clinical trial
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617633/pdf/main.pdf

Examination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799939

Gout and Excess Risk of Severe SARS-CoV-2 Infection Among Vaccinated Individuals: A General Population Study
https://onlinelibrary.wiley.com/doi/10.1002/art.42339

Covid-19 Vaccine Protection among Children and Adolescents in Qatar
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2210058?articleTools=true

Therapeutic advances in COVID-19
https://www.nature.com/articles/s41581-022-00642-4.pdf

Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US
https://www.bmj.com/content/bmj/379/bmj-2022-071594.full.pdf

Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose
https://www.nejm.org/doi/pdf/10.1056/NEJMc2211283?articleTools=true

Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549602/pdf/fimmu-13-992370.pdf

SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants
https://www.frontiersin.org/articles/10.3389/fimmu.2022.909995/pdf

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2209367?articleTools=true

Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2797625/strasser_2022_oi_221086_1666016864.51241.pdf

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
https://www.science.org/doi/epdf/10.1126/science.abo2523

A multinational Delphi consensus to end the COVID-19 public health threat
https://www.nature.com/articles/s41586-022-05398-2.pdf

ETF statement on the loss of activity of anti-spike protein monoclonal antibodies due to emerging SARS-CoV-2 variants of concern
https://www.ema.europa.eu/en/documents/public-statement/etf-statement-loss-activity-anti-spike-protein-monoclonal-antibodies-due-emerging-sars-cov-2_en.pdf

Allergists and COVID-vaccine: which is the actual risk of reactions in allergic patients?
https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13006/11057

Association of Symptoms After COVID-19 Vaccination With Anti–SARS-CoV-2 Antibody Response in the Framingham Heart Study
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797552

Duration of immunity following full vaccination against SARS-CoV-2: a systematic review
https://archpublichealth.biomedcentral.com/counter/pdf/10.1186/s13690-022-00935-x.pdf

Comparative effectiveness of N95, surgical or medical, and non-medical facemasks in protection against respiratory virus infection: A systematic review and network meta-analysis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111143/pdf/RMV-32-0.pdf

Antiviral Activity of Echinacea Extract Appears to Include SARS-CoV-2
https://www.herbalgram.org/media/17794/032223.pdf

COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis
https://www.frontiersin.org/articles/10.3389/fmed.2022.1023507/pdf

SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia
https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-022-02547-2.pdf

Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies
https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00663-6.pdf

Stevens-Johnson syndrome related with Comirnaty® coronavirus disease 2019 vaccine
https://www.scienceopen.com/document_file/3455a93b-637b-4964-8372-8a06712968c6/PubMedCentral/3455a93b-637b-4964-8372-8a06712968c6.pdf

Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants
https://www.nejm.org/doi/10.1056/NEJMc2209306

Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial
https://jamanetwork.com/journals/jama/fullarticle/2797483

SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia
https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-022-02547-2.pdf

Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies
https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00663-6.pdf

Stevens-Johnson syndrome related with Comirnaty® coronavirus disease 2019 vaccine
https://www.scienceopen.com/document_file/3455a93b-637b-4964-8372-8a06712968c6/PubMedCentral/3455a93b-637b-4964-8372-8a06712968c6.pdf

Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants
https://www.nejm.org/doi/10.1056/NEJMc2209306

Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial
https://jamanetwork.com/journals/jama/fullarticle/2797483

Allergists and COVID-vaccine: which is the actual risk of reactions in allergic patients?
https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13006/11057

Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality
in children in Argentina, during predominance of delta and omicron covid-19 variants: test
negative, case-control study
https://www.bmj.com/content/bmj/379/bmj-2022-073070.full.pdf 

Aportes de la biotecnología en el diagnóstico de COVID-19
https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/204/105

Adverse drug reactions reported following use of oral COVID-19 therapeutics in New Zealand
https://www.medsafe.govt.nz/profs/PUArticles/December2022/Adverse-drug-reactions-reported-
oral-COVID-19-therapeutics.html

Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US
Essential and Frontline Workers
https://jamanetwork.com/journals/jama/fullarticle/2797418?utm_source=substack&utm_mediu
m=email

What next for covid-19 vaccines?
https://www.bmj.com/content/379/bmj.o2422?utm_source=substack&utm_medium=email

Enfermedades dermatológicas inmunomediadas desencadenadas por la infección por SARS-CoV-2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500085/pdf/main.pdf

Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial
https://www.thelancet.com/pdfs/journals/ebiom/PIIS2352-3964(22)00480-7.pdf

Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428332/pdf/main.pdf

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2209367?articleTools=true

COVID-19 Diagnosis and Risk of Death Among Adults With Cancer in Indiana: Retrospective Cohort Study
https://cancer.jmir.org/2022/4/e35310/PDF

Análisis de las reacciones adversas a la vacuna contra COVID-19 en la población de la Zona Básica de Salud de Cantalejo
https://mgyf.org/wp-content/uploads/2022/11/MGYF2022_046-1.pdf

Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2796667?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092622

Association of Frailty, Age, and Biological Sex With Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine–Induced Immunity in Older Adults
https://academic.oup.com/cid/article-pdf/75/Supplement_1/S61/45407502/ciac397.pdf

Association Between Vaccination Status and Mortality Among Intubated Patients With COVID-19–Related Acute Respiratory Distress Syndrome
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797179

Effectiveness of mRNA COVID-19 Vaccine Boosters Against Infection, Hospitalization, and Death: A Target Trial Emulation in the Omicron (B.1.1.529) Variant Era
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575390/pdf/aim-olf-M221856.pdf

Association between menstrual cycle length and covid-19 vaccination: global, retrospective cohort study of prospectively collected data
https://bmjmedicine.bmj.com/content/bmjmed/1/1/e000297.full.pdf

Multi-Disciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) in Children and Adolescents
https://onlinelibrary.wiley.com/doi/pdf/10.1002/pmrj.12890

Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review
https://www.thelancet.com/action/showPdf?pii=S2589-5370%2822%2900354-6

Reaction of SARS-CoV-2 antibodies with other pathogens, vaccines, and food antigens
https://www.frontiersin.org/articles/10.3389/fimmu.2022.1003094/pdf

Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals
https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010799&type=printable

Vaccine-Induced Immune Thrombocytopenia and Thrombosis after the Sputnik V Vaccine
https://www.nejm.org/doi/pdf/10.1056/NEJMc2210813?articleTools=true

Association of COVID-19 Vaccination During Early Pregnancy With Risk of Congenital Fetal Anomalies
https://jamanetwork.com/journals/jamapediatrics/fullarticle/2790805

Hypersensitivity Reactions to COVID-19 Vaccines—Identify High-risk Children and Vaccinate the Rest
https://jamanetwork.com/journals/jamapediatrics/fullarticle/2789414

Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection
https://jamanetwork.com/journals/jama/fullarticle/2788986

Effects of Vaccination and Previous Infection on Omicron Infections in Children
https://www.nejm.org/doi/pdf/10.1056/NEJMc2209371?articleTools=true

Analysis of Vaccine Reactions After COVID-19 Vaccine Booster Doses Among Pregnant and Lactating Individuals
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2795998

Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360656/pdf/10549_2022_Article_6693.pdf

De las publicaciones a la práctica cotidiana: tocilizumab en pacientes con COVID-19 grave
https://www.medicinabuenosaires.com/revistas/vol82-22/n5/659.pdf

Association of Male Hypogonadism With Risk of Hospitalization for COVID-19
https://pubmed.ncbi.nlm.nih.gov/36053534/

Severity of COVID-19 among solid organ transplant recipients in Canada, 2020–2021: a prospective, multicentre cohort study
https://www.cmaj.ca/content/cmaj/194/33/E1155.full.pdf

Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004–20: a national surveillance study
https://www.thelancet.com/action/showPdf?pii=S2666-5247%2822%2900127-6

Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)
https://www.bmj.com/content/bmj/378/bmj-2022-071230.full.pdf

Assessment of Delayed Large Local Reactions After the First Dose of the SARS-CoV-2 mRNA-1273 Vaccine in Japan
https://jamanetwork.com/journals/jamadermatology/fullarticle/2792873

Risk of Appendicitis After mRNA COVID-19 Vaccination in a Danish Population
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2791667

Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy
https://www.nejm.org/doi/10.1056/NEJMc2205276

Síndrome de Guillain-Barré y trombocitopenia tras la vacunación contra el SARS-CoV-2 con Moderna. Descripción de un caso
https://neurologia.com/articulo/2022138

Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the Omicron outbreak in adults of 50 years and older in Argentina: a test-negative case-control study
https://www.medrxiv.org/content/10.1101/2022.09.25.22280341v2

Patients  with previous presumed immediate hypersensitivity  reactions  to polyethylene glycol (PEG)  can safely  receive the Pfizer BioNTech  BNT162b2 COVID-19  vaccine
https://onlinelibrary.wiley.com/doi/epdf/10.1111/imj.15821?utm_source=substack&utm_medium=email

Folic acid and methotrexate use and their association with COVID-19 diagnosis and mortality: a case–control analysis from the UK Biobank
https://bmjopen.bmj.com/content/bmjopen/12/8/e062945.full.pdf

Myocarditis After BNT162b2 COVID-19 Third Booster Vaccine in Israel
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439627/pdf/cir-146-802.pdf

Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial
https://www.bmj.com/content/bmj/378/bmj-2022-071245.full.pdf

Can vitamin D protect against covid-19?
https://www.bmj.com/content/bmj/378/bmj.o1822.full.pdf

Humoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain
https://www.nature.com/articles/s41598-022-19537-2.pdf

Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes
https://www.cell.com/action/showPdf?pii=S2666-3791%2822%2900271-3

Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex
https://www.ahajournals.org/doi/epdf/10.1161/CIRCULATIONAHA.122.059970

Association of Reduced Hospitalizations and Mortality Rates Among COVID-19-Vaccinated Patients With Heart Failure
https://www.onlinejcf.com/action/showPdf?pii=S1071-9164%2822%2900536-X

COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology
https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2356

Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study
https://www.bmj.com/content/bmj/378/bmj-2022-071416.full.pdf

Covid-19: Severe complications during pregnancy are more common in unvaccinated women, study finds
https://www.bmj.com/content/bmj/376/bmj.o117.full.pdf

Factores asociados a la anosmia y ageusia en pacientes COVID-19de una provincia peruana
https://revistas.udea.edu.co/index.php/iatreia/article/view/346608/20807098

SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants
https://www.frontiersin.org/articles/10.3389/fimmu.2022.909995/pdf

From publications to every day clinical practice: tocilizumab in patients with severe covid-19
https://www.medicinabuenosaires.com/revistas/vol82-22/destacado/original_7760.pdf

Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers
https://jamanetwork.com/journals/jama/fullarticle/2794072

Olfactory dysfunction but not COVID-19 severity predicts severity of cognitive sequelae following SARS-CoV-2 infection in Amerindian older adults
https://alz.confex.com/alz/2022/meetingapp.cgi/Paper/66868

Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2201662?articleTools=true

Association of Homologous and Heterologous Vaccine Boosters With SARS-CoV-2 Infection in BBIBP-CorV Vaccinated Healthcare Personnel
https://www.cureus.com/articles/103631-association-of-homologous-and-heterologous-vaccine-boosters-with-sars-cov-2-infection-in-bbibp-corv-vaccinated-healthcare-personnel

Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals
https://link.springer.com/content/pdf/10.1007/s10787-022-01027-6.pdf

Respuesta humoral inducida por la vacuna BBIBP-CorV/Sinopharm COVID-19 en trabajadores de primera línea
http://iaes.edu.ve/iaespro/ojs/index.php/bmsa/article/view/494/681

A Bivalent Omicron-Containing Booster Vaccine against Covid-19
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2208343?articleTools=true

Covid-19 vaccine does not affect sustained implantation rates after single euploid embryo transfer, a retrospective study with 4868 cases
https://academic.oup.com/humrep/article/37/Supplement_1/deac105.038/6619730

Placental pathology in women vaccinated and unvaccinated against SARS-CoV-2
https://www.ajog.org/action/showPdf?pii=S0002-9378%2822%2900515-4

A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine
https://journals.asm.org/doi/epdf/10.1128/mbio.01822-22

Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records
https://www.bmj.com/content/bmj/378/bmj-2022-071249.full.pdf

Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257064/pdf/bmj-2022-071502.pdf

COVID-19 VACCINE COMPARISON CHART from The Medical Letter
https://secure.medicalletter.org/downloads/1621g_table.pdf

Covid-19 Vaccines — Immunity, Variants, Boosters
https://www.nejm.org/doi/pdf/10.1056/NEJMra2206573?articleTools=true

Vaccine-Induced Immune Thrombocytopenia and Thrombosis after the Sputnik V Vaccine
https://www.nejm.org/doi/pdf/10.1056/NEJMc2210813?articleTools=true

Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2794318

Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis
https://www.cmaj.ca/content/cmaj/194/28/E969.full.pdf

Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2203209?articleTools=true

Social impact of the clinical trials on COVID-19-related vaccines and other drugs
https://www.esteve.org/capitulos/social-impact-of-the-clinical-trials-on-covid-19-related-vaccines-and-other-drugs-2/

Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants
https://www.nejm.org/doi/pdf/10.1056/NEJMc2210546?articleTools=true

Myocarditis and pericarditis have been reported with Nuvaxovid (Novavax COVID-19 Vaccine)
https://www.medsafe.govt.nz/safety/Alerts/nuvaxovid-myocarditis.asp

Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City
https://www.thelancet.com/action/showPdf?pii=S2665-9913%2822%2900190-4

Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases
https://www.gastrojournal.org/action/showPdf?pii=S0016-5085%2822%2900450-4

Relationship between ABO Blood Group Distribution and COVID-19 Infection in Patients Admitted to the ICU: A Multicenter Observational Spanish Study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181327/pdf/jcm-11-03042.pdf

Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination
https://www.science.org/doi/epdf/10.1126/sciadv.abm7201

Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
https://www.nature.com/articles/s41421-022-00435-w.pdf

Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination
https://www.science.org/doi/epdf/10.1126/sciimmunol.add4853

Venous Thromboembolism Prophylaxis in COVID-19: Making Sense of the Evidence
https://www.acpjournals.org/doi/10.7326/M22-1425

Oral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis
https://evidence.nejm.org/doi/pdf/10.1056/EVIDoa2200145

Outcomes of SARS-CoV-2 Reinfection
https://www.researchsquare.com/article/rs-1749502/v1

Multisystem Inflammatory Syndrome Temporally Related to COVID-19 in Children From Latin America and the Caribbean Region: A Systematic Review With a Meta-Analysis of Data From Regional Surveillance Systems
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082071/pdf/fped-10-881765.pdf

A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response
https://journals.lww.com/transplantjournal/Fulltext/2022/07000/A_Fourth_Dose_of_COVID_19_Vaccine_Does_Not_Induce.22.aspx

Covid-19 Vaccines — Immunity, Variants, Boosters
https://www.nejm.org/doi/pdf/10.1056/NEJMra2206573?articleTools=true

Two new oral antivirals for covid-19: molnupiravir and nirmatrelvir plus ritonavir
https://dtb.bmj.com/content/dtb/60/5/73.full.pdf

Caracterización de las manifestaciones cutáneas por infección de SARS-COV-2 en pacientes de América Latina
https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S0213925122001083

Reactivación del virus varicela zóster tras la vacunación contra la COVID-19
https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S021392512200137X

Lesiones acroisquémicas tras la vacunación contra la COVID-19
https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S0213925122000582

Vasculitis leucocitoclástica asociada a la vacuna ARNm contra la COVID-19
https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S0213925122001381

Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037186/pdf/bjgpjul-2022-72-720-butler-fl-oa-p.pdf

Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial
https://www.thelancet.com/action/showPdf?pii=S2213-2600%2822%2900163-1

Mikania glomerata Spreng. (Asteraceae): seu uso terapêutico e seu potencial na Pandemia de COVID-19
https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1292/1037

mRNA-based COVID-19 Vaccines Booster Dose: Benefits, Risks and Coverage
https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13103/10836

The Effect of Diabetes Mellitus on Mortality in Patients Hospitalized Intensive Care Unit in Covid-19 Pandemic
https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/11880/10858

Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2
https://www.journalofinfection.com/action/showPdf?pii=S0163-4453%2822%2900248-1

Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19)
https://www.nature.com/articles/s41598-022-13920-9

Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00426-1/fulltext

Reactivación de glomerulonefritis lúpica en asociación temporal con vacunas anti sars-cov-2
https://www.medicinabuenosaires.com/revistas/vol82-22/destacado/casuistica_7802.pdf

Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study
https://www.thelancet.com/action/showPdf?pii=S2213-8587%2822%2900158-9

Protection vaccinale et immunité « naturelle » face à la COVID-19 : équivalence ?
http://www.minerva-ebm.be/FR/GetPdf/2306?articleId=2262

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases
https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjd.19163

Frequency of Neurological Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia
https://www.frontiersin.org/articles/10.3389/fneur.2022.904796/full

Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial

https://www.thelancet.com/action/showPdf?pii=S2213-2600%2822%2900186-2

Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people
https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00427-3.pdf

Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA1273
https://www.cell.com/cell-reports-medicine/pdf/S2666-3791(22)00248-8.pdf

Drug treatments for covid-19: living systematic review and network meta-analysis
https://www.bmj.com/content/370/bmj.m2980#:~:text=Conclusions,patients%20with%20severe%20covid%2D19.

Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288143/pdf/main.pdf

Autoimmune hepatitis and COVID-19: No increased risk for AIH after vaccination but reduced care
https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2822%2900120-9

Autoimmune hepatitis (AIH) following coronavirus (COVID-19) vaccine – no longer exclusive to mRNA vaccine?
https://onlinelibrary.wiley.com/doi/abs/10.1111/liv.15350

Virologic and Immunologic Characterization of COVID-19 Recrudescence after Nirmatrelvir/Ritonavir Treatment
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac496/6611663?login=false

Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2793109

Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757475/pdf/KGMI_14_2018899.pdf

Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac446/6603291?login=false

Application of normative documents for determination of biocidal activity of disinfectants and antiseptics dedicated to the medical area: a narrative review
https://www.journalofhospitalinfection.com/action/showPdf?pii=S0195-6701%2822%2900108-6

Frequency of Neurological Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia
https://www.frontiersin.org/articles/10.3389/fneur.2022.904796/full

Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial
https://www.medrxiv.org/content/10.1101/2022.06.10.22276252v1

Lesiones faciales de vitíligo tras la administración de la vacuna frente a SARS-CoV-2
https://www.actasdermo.org/es-pdf-S0001731022001600

Uso de ciclosporina en dermatología durante la pandemia de COVID-19
https://www.actasdermo.org/es-pdf-S0001731022004124

Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2201300?articleTools=true

Risk factors for SARS-CoV-2 infection and transmission in households with asthmatic and allergic children. A prospective surveillance study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155183/

Targeting SARS-CoV-2: An overview of COVID-19 treatments
https://www.medsafe.govt.nz/profs/PUArticles/June2022/Targeting-SARs-CoV-2-Overview-COVID-19-treatments.html

Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2792068

Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens
https://www.thelancet.com/action/showPdf?pii=S2468-1253%2822%2900166-2

Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm
https://molmed.biomedcentral.com/track/pdf/10.1186/s10020-022-00483-8.pdf

Advances in respiratory protective equipment: practical experiences of CleanSpace® HALO™ by healthcare workers
https://www.journalofhospitalinfection.com/article/S0195-6701(22)00078-0/fulltext#relatedArticles

Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis
https://www.bmj.com/content/377/bmj-2022-069989

Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2118946

Epidemiology of VITT (Vaccine-induced immune thrombotic thrombocytopenia)
https://www.sciencedirect.com/science/article/pii/S0037196322000051

COVID-19 mRNA Vaccines Preserve Immunogenicity after Re-Freezing
https://www.mdpi.com/2076-393X/10/4/594

Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial
https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/11958/10756

Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance
https://jamanetwork.com/journals/jama/fullarticle/2792524

Mortality in COVID-19 among women on hormone replacement therapy: a retrospective cohort study
https://academic.oup.com/fampra/advance-article/doi/10.1093/fampra/cmac041/6585930?login=false

Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
https://journals.plos.org/plosmedicine/article/authors?id=10.1371/journal.pmed.1003991

Effect of polymerised type I collagen on hyperinflammation of adult outpatients with symptomatic COVID-19
https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctm2.763

BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2205011

Cetylpyridinium Chloride Mouthwash to Reduce Shedding of Infectious SARS-CoV-2: A Double-Blind Randomized Clinical Trial
https://journals.sagepub.com/doi/10.1177/00220345221102310

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022
https://www.thelancet.com/action/showPdf?pii=S0140-6736%2822%2901185-0

Imbalance in baseline characteristics in molnupiravir trials
https://www.bmj.com/content/377/bmj.o977

Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2791533

Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine
https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.3465

Two new oral antivirals for covid-19: molnupiravir and nirmatrelvir plus ritonavir
https://dtb.bmj.com/content/dtb/60/5/73.full.pdf

Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis
https://www.bmj.com/content/bmj/377/bmj-2022-069989.full.pdf

Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022
https://www.cdc.gov/mmwr/volumes/71/wr/pdfs/mm7111e1-H.pdf

Effect of Early Treatment with Ivermectin among Patients with Covid-19
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2115869?articleTools=true

Antibody durability at 1 year after Sputnik V vaccination
https://www.thelancet.com/action/showPdf?pii=S1473-3099%2822%2900176-1

Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies
https://www.sciencedirect.com/science/article/pii/S0033350621004741?via%3Dihub

SARS-CoV-2 vaccine-associated-tinnitus: A review
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788157/pdf/main.pdf

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2201570?articleTools=true

SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum, but evades most convalescent serum and therapeutic antibodies
https://www.science.org/doi/epdf/10.1126/scitranslmed.abn8543

Inhibition of Respiratory RNA Viruses by a Composition of Ionophoric Polyphenols with Metal Ions

https://www.mdpi.com/1424-8247/15/3/377/htm

Effect of Early Treatment with Ivermectin among Patients with Covid-19
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2115869?articleTools=true

Risks and burdens of incident diabetes in long COVID: a cohort study
https://www.sciencedirect.com/science/article/pii/S2213858722000444

Persistent COVID-19 Infection in Wiskott-Aldrich Syndrome Cleared Following Therapeutic Vaccination: a Case Report
https://link.springer.com/content/pdf/10.1007/s10875-021-01158-5.pdf

Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities
The I-TECH Randomized Clinical Trial
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362

The presence of serum anti-SARS-CoV-2 IgA appears to protect primary health care workers from COVID-19
https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202149655

Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir
https://www.dovepress.com/getfile.php?fileID=79350

COVID-19-Associated Croup in Children
https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2022-056492/185378/COVID-19-Associated-Croup-in-Children

Autoimmune hepatitis and COVID-19: No increased risk for AIH after vaccination but reduced care
https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2822%2900120-9

SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis
https://www.journal-of-hepatology.eu/article/S0168-8278(22)00234-3/pdf

BNT162b2 Protection against the Omicron Variant in Children and Adolescents
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2202826?articleTools=true

Management of Drug Interactions With Nirmatrelvir/Ritonavir (Paxlovid®): Resource for Clinicians
https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/treatment/idsa-paxlovid-drug-interactions-resource-5-6-22-v1.1.pdf

Durability of SARS-CoV-2 Antibodies From Natural Infection in Children and Adolescents
https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2021-055505/185412/Durability-of-SARS-CoV-2-Antibodies-From-Natural

Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2200674?articleTools=true

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2118691?articleTools=true

Ministerio de Salud: Recomendaciones

 

Organización Panamericana de la Salud (OPS) – Argentina / CDC

Actualización semanal COVID-19 – Argentina
https://www.paho.org/es/actualizacion-semanal-covid-19-argentina

OPS: cursos sobre COVID-19 en español
https://www.campusvirtualsp.org/es/covid-19

OPS Recursos de información relacionados con el nuevo coronavirus
https://www.paho.org/arg/index.php?option=com_content&view=article&id=10430:coronavirus&Itemid=226

Vitrina del conocimiento: Nuevo coronavirus
https://bvsalud.org/vitrinas/es/post_vitrines/nuevo_coronavirus/

CDC –  Centros para el Control y la Prevención de Enfermedades – USA Recomendaciones, cómo protegerse
https://espanol.cdc.gov/enes/coronavirus/2019-ncov/index.html

Clasificaciones y definiciones de las variantes del SARS-CoV-2
https://espanol.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html

 

.